American Society of Clinical Oncology

SHERPA: White

People

  1. Kelsen
    Kelsen
  2. Capanu
    Capanu
  3. Ilson
    Ilson
  4. Janjigian
    Janjigian
  5. Gonen
    Gonen
  6. Coit
    Coit
  7. Strong
    Strong
  8. Brennan
    Brennan
  9. Bains
    Bains
  10. O'Reilly
    O'Reilly

Groups

  1. Epidemiology and Biostatistics (31)
  2. Biostatistics Service (30)
  3. Center for Pancreatic Cancer Research (30)
  4. Department of Medicine (27)
  5. Gastrointestinal Oncology Service (26)
  6. Solid Tumor Oncology Division (26)
  7. Survivorship Research (12)
  8. Surgery (11)
  9. Radiology, Department of (8)
  10. Melanoma Disease Management Team (7)
Search Within
  1. "Manish Shah"
  2. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (27)
  2. Journal Article (4)
Groups
  1. Epidemiology and Biostatistics (31)
  2. Biostatistics Service (30)
  3. Center for Pancreatic Cancer Research (30)
  4. Department of Medicine (27)
  5. Gastrointestinal Oncology Service (26)
  6. Solid Tumor Oncology Division (26)

More Groups

People
  1. Manish Shah (31)
  2. David Kelsen (25)
  3. Marinela Capanu (19)
  4. David Ilson (15)
  5. Yelena Janjigian (11)
  6. Mithat Gonen (10)

More People

Years
  1. 2015 (2)
  2. 2014 (1)
  3. 2013 (3)
  4. 2012 (2)
  5. 2011 (5)
  6. 2010 (4)

More Years

Publications
  1. Journal of Clinical Oncology (31)

Results (31)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized multicenter phase II study of modified docetaxel, cisplatin, and fluorouracil (DCF) versus DCF plus growth factor support in patients with metastatic gastric adenocarcinoma: A study of the US gastric cancer consortium
    Journal Article

    Shah, M. A.; Janjigian, Y. Y.; Stoller, R.; Shibata, S.; Kemeny, M.; Krishnamurthi, S.; Bernard, Su, Y.; Ocean, A.; Capanu, M.; Mehrotra, B.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Identification of the gastric microbiome from endoscopic biopsy samples using whole genome sequencing
    Meeting Abstract

    Zhang, C.; Cleveland, K.; Schnoll-Sussman, F.; McClure, B.; Bigg, M.; Thakkar, P.; Schultz, N.; Pamer, E. G.; Betel, D.; Shah, M. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Evaluation of PET response to neoadjuvant therapy for patients with gastric and GEJ adenocarcinoma
    Meeting Abstract

    Hernandez, J. M.; Beylergil, V.; Goldman, D.; Schoder, H.; Gonen, M.; Tang, L. H.; Downey, R. J.; Shah, M. A.; Strong, V. E.; Coit, D. G.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II study of preoperative chemotherapy plus bevacizumab with early salvage therapy based on FDG-PET response in patients with locally advanced gastric and GEJ adenocarcinoma
    Meeting Abstract

    Won, E.; Ilson, D.; Kelsen, D. P.; Strong, V. E.; Schoder, H.; Janjigian, Y. Y.; Shah, M. A.; Coit, D. G.; Brennan, M. F.; Capanu, M.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response and prolonged stable disease observed in adenocarcinoma
    Meeting Abstract

    Ku, G. Y.; Janjigian, Y. Y.; Shah, M. A.; Herrera, J.; Tang, L. H.; Fuqua, L.; Capanu, M.; Ilson, D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Preoperative chemotherapy plus bevacizumab with early salvage therapy based on FDG-PET response in locally advanced gastroesophageal junction and gastric adenocarcinoma
    Meeting Abstract

    Ku, G. Y.; Kelsen, D. P.; Strong, V. E.; Schòˆder, H.; Janjigian, Y. Y.; Shah, M. A.; Coit, D. G.; Brennan, M. F.; Capanu, M.; Ilson, D. H.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of bevacizumab, irinotecan, cisplatin, and radiation as preoperative therapy in esophageal adenocarcinoma
    Meeting Abstract

    Ilson, D.; Goodman, K. A.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Rizk, N. P.; Rusch, V. W.; Wu, A. J. C.; Campbell, J.; Capanu, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of bevacizumab, irinotecan, cisplatin, and radiation as preoperative therapy in esophageal adenocarcinoma
    Meeting Abstract

    Ilson, D.; Goodman, K. A.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Rizk, N. P.; Rusch, V. W.; Wu, A. J. C.; Campbell, J.; Capanu, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response and protracted stable disease observed in adenocarcinoma
    Meeting Abstract

    Ilson, D.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Tang, L. H.; Campbell, J.; Fuqua, L.; Capanu, M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Quality of life in patients with advanced gastroesophageal (GE) adenocarcinoma treated with modified docetaxel, cisplatin, and fluorouracil (mDCF)
    Meeting Abstract

    Smyth, E. C.; Janjigian, Y. Y.; Robinson, E.; Sheehy, E. C.; Karpenko, I.; Capanu, M.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save